انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
The Future of Pharmacometrics with Dr. Nathan Teuscher
Manage episode 459563101 series 3593861
In this episode of BioTalk Unzipped, hosts Gregory Austin and Chad Briscoe welcome Dr. Nathan Teuscher, a seasoned expert in clinical pharmacology and pharmacometrics. The conversation explores Nathan's career journey, the innovative charity Light the World, and the transformative role of AI in drug development. They discuss the challenges and opportunities presented by AI, particularly in automating data analysis and rethinking traditional reporting methods in the pharmaceutical industry. The episode emphasizes the potential for small companies to leverage cloud-based tools and APIs to enhance efficiency and drive innovation in drug development. In this conversation, the speakers explore the intersection of data analysis, AI tools, and advancements in gene editing with organ transplants.
Chapters
00:00 Episode Preview
00:55 Introduction to BioTalk Unzipped
02:06 Charity Spotlight: Light of the World
04:51 Nathan Teuscher's Career Journey
07:34 Differentiating AI Types in Life Science
12:41 Challenges with Large Language Models
15:39 Rethinking Reporting in Pharma
17:56 The Future of AI and Analytics in Pharma?
18:52 Leveraging APIs (Application Programming Interfaces) for Small Companies
23:05 Leveraging Data, AI, and APIs in 3 Dimensions
26:22 NEW NEWS! - Gene Editing Breakthroughs in Medicine
How to reach us:
Light the World Charity - Church of Jesus Christ Latter Day Saints
https://www.churchofjesuschrist.org/comeuntochrist/light-the-world
Nathan Teuscher
https://www.linkedin.com/in/nathanteuscher/
Aplos Analytics - https://aplosanalytics.com/
Nathan Teuscher’s Podcast: Clinical Pharmacology Podcast
https://teuschersolutions.com/
Collaboration with BioTalk Unzipped (Ep. 40)
Dr. Chad Briscoe
https://www.linkedin.com/in/chadbriscoe/
Celerion - https://www.celerion.com/
Gregory Austin
https://www.linkedin.com/in/gregoryaustin1/
ECI - https://eci-rx.com /
Sound Bites
"We don't need to write reports anymore."
Takeaways
Nathan Teuscher has over 20 years of experience in clinical pharmacology and pharmacometrics.
Light the World charity offers unique giving machines for donations.
AI can automate repetitive tasks in drug development, freeing up human capital for innovation.
There are two types of AI: large language models and automated data analysis.
Large language models can be unreliable in scientific contexts.
Pharmaceutical companies spend significant resources on report writing, which may not add value.
Small companies can leverage APIs to access standardized calculations and data analysis.
The pharmaceutical industry is often insular, limiting the potential of AI.
AI could potentially eliminate the need for extensive written reports in drug development.
Collaboration and data sharing are crucial for advancing AI in the pharmaceutical industry. Leveraging data effectively requires combining various data sets and tools.
The evolution of AI tools is crucial for navigating new technologies.
Gene editing represents a significant breakthrough in organ transplantation.
New News Story:
A woman in the US is the third person to receive a gene-edited pig kidney
Image Credits
Keywords
BioTalk, pharmacology, AI in pharma, drug development, pharmacometrics, software development, clinical research, Light the World, charity, data analysis, AI tools, gene editing, kidney transplant, pharmaceuticals, virtual trials, healthcare innovation, drug development, patient engagement, medical technology, drug dosage, oncology, FDA approval, cell therapy, immunocompromised, collaboration, success, clinical pharmacology, podcast, healthcare
29 حلقات
Manage episode 459563101 series 3593861
In this episode of BioTalk Unzipped, hosts Gregory Austin and Chad Briscoe welcome Dr. Nathan Teuscher, a seasoned expert in clinical pharmacology and pharmacometrics. The conversation explores Nathan's career journey, the innovative charity Light the World, and the transformative role of AI in drug development. They discuss the challenges and opportunities presented by AI, particularly in automating data analysis and rethinking traditional reporting methods in the pharmaceutical industry. The episode emphasizes the potential for small companies to leverage cloud-based tools and APIs to enhance efficiency and drive innovation in drug development. In this conversation, the speakers explore the intersection of data analysis, AI tools, and advancements in gene editing with organ transplants.
Chapters
00:00 Episode Preview
00:55 Introduction to BioTalk Unzipped
02:06 Charity Spotlight: Light of the World
04:51 Nathan Teuscher's Career Journey
07:34 Differentiating AI Types in Life Science
12:41 Challenges with Large Language Models
15:39 Rethinking Reporting in Pharma
17:56 The Future of AI and Analytics in Pharma?
18:52 Leveraging APIs (Application Programming Interfaces) for Small Companies
23:05 Leveraging Data, AI, and APIs in 3 Dimensions
26:22 NEW NEWS! - Gene Editing Breakthroughs in Medicine
How to reach us:
Light the World Charity - Church of Jesus Christ Latter Day Saints
https://www.churchofjesuschrist.org/comeuntochrist/light-the-world
Nathan Teuscher
https://www.linkedin.com/in/nathanteuscher/
Aplos Analytics - https://aplosanalytics.com/
Nathan Teuscher’s Podcast: Clinical Pharmacology Podcast
https://teuschersolutions.com/
Collaboration with BioTalk Unzipped (Ep. 40)
Dr. Chad Briscoe
https://www.linkedin.com/in/chadbriscoe/
Celerion - https://www.celerion.com/
Gregory Austin
https://www.linkedin.com/in/gregoryaustin1/
ECI - https://eci-rx.com /
Sound Bites
"We don't need to write reports anymore."
Takeaways
Nathan Teuscher has over 20 years of experience in clinical pharmacology and pharmacometrics.
Light the World charity offers unique giving machines for donations.
AI can automate repetitive tasks in drug development, freeing up human capital for innovation.
There are two types of AI: large language models and automated data analysis.
Large language models can be unreliable in scientific contexts.
Pharmaceutical companies spend significant resources on report writing, which may not add value.
Small companies can leverage APIs to access standardized calculations and data analysis.
The pharmaceutical industry is often insular, limiting the potential of AI.
AI could potentially eliminate the need for extensive written reports in drug development.
Collaboration and data sharing are crucial for advancing AI in the pharmaceutical industry. Leveraging data effectively requires combining various data sets and tools.
The evolution of AI tools is crucial for navigating new technologies.
Gene editing represents a significant breakthrough in organ transplantation.
New News Story:
A woman in the US is the third person to receive a gene-edited pig kidney
Image Credits
Keywords
BioTalk, pharmacology, AI in pharma, drug development, pharmacometrics, software development, clinical research, Light the World, charity, data analysis, AI tools, gene editing, kidney transplant, pharmaceuticals, virtual trials, healthcare innovation, drug development, patient engagement, medical technology, drug dosage, oncology, FDA approval, cell therapy, immunocompromised, collaboration, success, clinical pharmacology, podcast, healthcare
29 حلقات
كل الحلقات
×مرحبًا بك في مشغل أف ام!
يقوم برنامج مشغل أف أم بمسح الويب للحصول على بودكاست عالية الجودة لتستمتع بها الآن. إنه أفضل تطبيق بودكاست ويعمل على أجهزة اندرويد والأيفون والويب. قم بالتسجيل لمزامنة الاشتراكات عبر الأجهزة.